abstract |
Compounds of formula (I) of pharmaceutically acceptable salts thereof are provided: formula (I), which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia. |